BA
CVET

Boston Advisors’s Covetrus, Inc. Common Stock CVET Stock Holding History

Boston Advisors’s Portfolio CVET Stock Details CVET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.25M Buy
104,808
+31,643
+43% +$586K 0.07% 352
2019
Q2 		$1.79M Sell
73,165
-2,452
-3% -$70.6K 0.1% 240
2019
Q1 		$2.41M Buy
+75,617
New +$2.68M 0.12% 203

Other funds holding CVET

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Boston Advisors's CVET Position: Q3 2019 in Review

Boston Advisors increased its Covetrus, Inc. Common Stock (CVET) stake by 43% in Q3 2019, buying an estimated $586K and bringing the position to 104,808 shares worth $1.25M. The position accounts for 0.07% of the portfolio, ranked #352.

Boston Advisors first reported a position in CVET in Q1 2019 and has held it in 3 quarters since. The position peaked at $2.41M in Q1 2019. 282 funds tracked by Wall St. Rank hold CVET as of Q3 2019.

  • Boston Advisors held 104,808 shares of Covetrus, Inc. Common Stock worth $1.25M as of Q3 2019.
  • Boston Advisors bought 31,643 Covetrus, Inc. Common Stock shares in Q3 2019, an estimated $586K.
  • Covetrus, Inc. Common Stock made up 0.07% of Boston Advisors's portfolio in Q3 2019, its #352 holding.
  • Boston Advisors first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and has held it in 3 quarters since.
  • Boston Advisors's Covetrus, Inc. Common Stock position peaked at $2.41M in Q1 2019.
  • 282 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2019.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.